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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S265Conclusions: Increased vibratory acuity was associatedwith both lower
PPTs and the presence of TS in this large cohort of persons with or at risk
of knee OA. Increased vibratory acuity also appeared to modify the
association between low PPT and radiographic OA in this cross-
sectional analysis. Thus vibratory sense may be an additional somato-
sensorymeasurewith relevance to central sensitization and nociceptive
processing in persons with knee OA.Table
Relationship between VPT, PPT with tibiofemoral radiographic OA
VPT and PPT combo Adjusted* Prevalence
Ratio (95% CI)
p-value
PPT VPT
Low Low 1.36 (1.16-1.60) 0.0001
Middle 1.07 (0..95-1.20) 0.3
High 1.19 (0.97-1.45) 0.1
Middle Low 0.99 (0.86-1.14) 0.8
Middle REF
High 1.03 (0.90-1.90) 0.6
High Low 1.11 (0.76-1.61) 0.6
Middle 1.05 (0.91-1.21) 0.5
High 1.17 (0.92-1.49) 0.2
*Adjusted for age, sex, BMI, race, clinical site, CES-D, widespread pain, and
catastrophizing513
CHARACTERIZATION OF MONOSODIUM IODOACETATE-INDUCED
LOCOMOTOR ACTIVITY IMPAIRMENT IN RATS
A. Pekcec, L. Corradini, H. Doods. Boehringer Ingelheim Pharma GmbH &
Co. KG, Biberach an der Riss, Germany
Purpose: Activity measurement in rodents has been suggested as
a novel approach to evaluate analgesic effects of drugs on ongoing pain
without using reﬂexive, withdrawal threshold measures. In the present
studies, we characterized spontaneous activity deﬁcits in the rat mon-
osodium iodoacetate (MIA) model of osteoarthritis pain and compared
activity deﬁcits with those induced in a different inﬂammatory model
of pain, the Complete Freunds Adjuvant (CFA) model. Furthermore, the
effect of standard analgesics onMIA or CFA induced activity deﬁcits was
evaluated and compared.
Methods: Male Wistar-Han rats (Charles River, Germany) were used to
induce knee joint inﬂammation by bilateral injections of 3mg/kg MIA
(Sigma, Germany) solved in 50ml saline. Three days later locomotor
activity was observed over 30 minutes in an open ﬁeld by using an
activity monitoring system (Harvard Apparatus, MA, USA). Sham rats
received i.e. administration of saline instead of MIA injection. For the
CFA studies, 100mg of CFA (Sigma, Germany) was injected in a total
volume of 100ml intraplantar into one or both paws. Locomotor activity
was determined the next day. Sham treated animals received the same
amount of intraplantar saline injections.
Results: Rats withMIA injection showed a decrease of the total distance
travelled, rearing frequency as well as the total rearing time compared
to Sham treated animals and naive controls. Single-dose administration
of different doses of indomethacin or celebrex (that are efﬁcacious in
evoked measures of pain) did not attenuate activity deﬁcits induced by
MIA. Also, repeated treatment with celebrex over 3 days did not
attenuate MIA-induced locomotor activity impairments. Acute p.o.
administration of tramadol reduced MIA induced activity deﬁcits
without impairment of activity in controls whereas subcutaneous
injections of morphine impaired locomotor activity in both MIA and
control rats. In contrast, single-dose administration of indomethacin,
celebrex and tramadol (that are efﬁcacious in evoked measures of pain)
attenuated activity deﬁcits in CFA rats without inﬂuencing activity
parameters in control animals. Similar to MIA rats, morphine impaired
locomotor activity in control rats as well as CFA rats.
Conclusions: The data of this study indicate impaired spontaneous
activity in the rat MIA model of inﬂammatory osteoarthritis. Although
these activity deﬁcits appear to be less pronounced as compared to
those observed in the intraplantar CFA model, the treatment response
to different clinically used analgesics differs suggesting major differ-
ences in the underlying inﬂammatory processes. The data moreover
suggest that activity measurements in the rodent MIA model of oste-
oarthritis present as an interesting functional behavioral readout foranalgesic drug effects that does not require habituation of the animal
and is thus less prone to observation subjectivity.
The current study was done as a BI contribution to the “EUROPAIN”
project within the European Consortium “Innovative Medicine Initia-
tive”. The authors thank Andreas Sterner for technical assistance.
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STRUCTURAL BRAIN ALTERATIONS IN INDIVIDUALS WITH CHRONIC
JOINT PAIN
M. de Kruijf, D. Bos, F.J. Huijgen, A. Hofman, M.W. Vernooij, A.G.
Uitterlinden, M.A. Ikram, J.B. van Meurs. Erasmus MC, Rotterdam, The
Netherlands
Purpose: The severity of pain reported by OA patients does not always
reﬂect the extent of detectable joint pathology. Identiﬁcation of the
areas of the brain involved in development of chronic joint pain could
provide insight into these observed discrepancies. Long term changes in
the brain can be detected by examining structural brain changes, which
reﬂect adaptive reorganization of the nervous system. Previous studies
examining structural brain alterations in subjects with chronic (joint)
pain were all performed in small case-control studies, using not more
than 60 patients and usually using voxel based techniques which may
be subject to false positive ﬁndings due to multiple testing. In the
current study, we examined brain volume alterations in a large pop-
ulation based study (n¼3967) and used state-of-the art tools to
segment brain structures.
Methods: This study was performed in the Rotterdam study,
a prospective population-based cohort study of individuals aged 45
years and over. In 3967 subjects, in whom magnetic resonance imaging
(MRI) of the brain was performed, brain volumes were segmented and
quantiﬁed in millilitres. We ﬁrst investigated the association of chronic
joint pain with global volumes of grey matter; after which we
segmented the brain volumes into four main lobes (frontal, temporal,
parietal and occipital). Subsequently, we investigated the association of
chronic joint pain with volumes of structures that are part of the limbic
system or are involved in signal processing (hippocampus, amygdala,
thalamus and caudate). Chronic joint painwas deﬁned as having pain in
one or more joints for more than half of the days in the last six weeks,
and the subjects should have visited a medical doctor for this pain.
Association analyses were performed with Z-score normalised volumes,
stratiﬁed on gender and adjusted for intracranial volume, age and the
presence of depression according to the self reporting CES-D scale.
Results: A total of 3383 subjects (1527 males and 1856 females) with
both MRI and pain data were available for analysis. Chronic joint pain
was present in 27% of the male subjects and in 42% of the female
subjects. Total grey matter volume was signiﬁcantly smaller in female
subjects with chronic joint pain (Beta -0.06; p-value 0.031), which was
primarily located in the temporal lobe (Beta -0.08; p-value 0.011) and
a trend for the frontal lobe (Beta 0.06; p-value 0.057). Since involve-
ment of the frontal and temporal lobe suggested involvement of the
limbic system, we subsequently studied these structures further. Again
only in females, a signiﬁcant smaller hippocampal volume was found
(Beta -0.10; p-value 0.003). All these association were independent of
age and presence of depression symptoms. No clear associations with
the studied brain structures were found in males.
Conclusions: We found a signiﬁcantly smaller grey matter volumes in
the brain of females with chronic joint pain, speciﬁcally in the temporal
lobe and hippocampus. The location of this identiﬁed areas point
towards the involvement of emotional processing, in females with
chronic joint pain. The fact that this is not found in men might indicate
a sexually dimorphic handling of pain, which might have consequences
for the treatment of pain between the two sexes.515
INVESTIGATING A ROLE FOR TNF-ALPHA IN MCP-1 UPREGULATION
IN THE KNEE AND DRG IN THE DMM MODEL
R.E. Miller, P.B. Tran, A.-M. Malfait. Rush Univ. Med. Ctr., Chicago, IL, USA
Purpose: We recently reported that MCP-1/CCR2 signaling mediates
the development of movement-provoked pain in a mouse model of
osteoarthritis (OA) induced by destabilization of the medial meniscus
(DMM). At 8 weeks post DMM, monocyte chemoattractant protein
(MCP)-1 and CCR2 were upregulated in the innervating dorsal root
ganglia (DRG), and this correlated with the onset of decreased
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S266locomotion. Ccr2 null mice were protected from these locomotion
decreases, despite similar joint damage at 8 weeks post DMM, and
Ccr2 null DRG did not produce MCP-1. Therefore, we sought to further
investigate the expression and regulation of MCP-1 in the DMM
model. The current goals were to: 1) Test whether TNF-a induces
MCP-1 production in DRG cells, since it has been shown that TNF-
a induces Mcp-1 mRNA in cultured DRG cell lines. 2) Analyze MCP-1
protein content in the knees of wild-type (WT) and Ccr2 null mice after
DMM.
Methods: Knee-innervating DRG, L3-L5, were collected from 10-week
old naïve C57BL/6 WT or Ccr2 null mice. Cells were isolated and
cultured for 2 days in basal medium before 48 h-stimulation with 0, 25,
or 100 ng/mL TNF-a; supernatants were collected for MCP-1 ELISA. Hip
cartilage explants were harvested from 5-week old naove C57BL/6mice.
Hip cartilage was used since it is not possible to culture mouse knee
cartilage explants. Explants were rested overnight, stimulated with 100
ng/mL TNF-a for 48 h, and supernatants were collected for MCP-1 ELISA.
DMM or sham surgery was performed in the right knees of 10-week old
male C57BL/6 WT or Ccr2 null (Taconic #3736) mice. At 0, 4, and 8
weeks after surgery, whole knee joints were extracted for ELISA. At 4 or
8 weeks post surgery, DRG cells were cultured for 4 days and super-
natants collected for ELISA.
Results: In order to test whether TNF-a is able to stimulate primary DRG
cells to produce MCP-1 protein, we treated naïve WT DRG cells with
TNF-a. Cultures stimulated with 25 ng/mL TNF-a produced 37-fold
increased amounts of MCP-1 compared to unstimulated cells
(p<0.0001); a higher concentration of 100 ng/mL TNF-a did not further
increase MCP-1. This conﬁrms earlier reports of increased Mcp-1 mRNA
following TNF-a stimulation. DRG cells from naïve Ccr2 null mice
responded in the same way to TNF-a.
We looked for the presence of TNF-a in cultures of DRG cells taken from
WT or Ccr2 null naïve, sham, or DMM mice at 4 and 8 weeks post
surgery. None of these cultures contained measurable amounts of
TNF-a.
Next, we determined MCP-1 levels in whole knee joint extracts after
DMM inWT and Ccr2 null mice. In WT, knee MCP-1 protein levels were
elevated 4 weeks post DMM, compared to sham and naïve age-matched
controls (p<0.0001); by 8 weeks post DMM, levels had returned to
baseline. MCP-1 was also increased in knee extracts from Ccr2 null
mice, 4 weeks after DMM, but to a lesser extent than in WT. In order to
determine the potential source of MCP-1 in the knee, we began by
testing whether cartilage is able to produce MCP-1. Cartilage explants
stimulated with 100 ng/mL TNF-a produced 86-fold increased levels of
MCP-1 compared to unstimulated explants (p¼0.0008). When we
looked for the presence of TNF-a in knee extracts, however, we found
that DMM and naïve extracts contained similar low levels of TNF-a at 4
and 8 weeks post surgery. TNF-a levels in Ccr2 null knee extracts
mirrored the WT results, with no difference at 4 or 8 weeks between
DMM and naïve extracts.
Conclusions: These observations conﬁrm that TNF-a can stimulate DRG
neurons and cartilage explants to produce MCP-1 protein, conﬁrming
previous reports that TNF-a induces MCP-1 mRNA in these tissues. We
did not, however, detect elevated TNF-a levels in the DRG or in the knee
joint in situ in the DMM model at 4 or 8 weeks post surgery. It is
possible that TNF-a upregulation occurs at earlier time points than the
ones studied here (McNamee et al 2010 reported TNF-a mRNA in the
knee at 3 days post DMM) or that other factors are driving MCP-1
production.
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FINGER LENGTH PATTERN AS A BIOMARKER FOR PRENATAL
ANDROGEN EXPOSURE AND THE RISK FOR OSTEOARTHRITIS AND
PAIN
M. de Kruijf, H.J. Kerkhof, S. Bierma-Zeinstra, C. Zillikens, A.G.
Uitterlinden, F.J. Huijgen, J.B. van Meurs. Erasmus MC, Rotterdam, The
Netherlands
Purpose: The prevalence of type 3 ﬁngerlength pattern, determined by
a shorter 4th digit compared to the 2nd digit, is inﬂuenced by prenatal
androgen exposure and has been studied previously as a biomarker for
gender differences in the risk of several traits. Osteoarthritis (OA) and
chronic musculoskeletal pain are both sexually dimorphic. In this study,
we evaluate the association of ﬁngerlength type, as a marker of prenatal
androgen exposure, with the risk of osteoarthritis (OA) and chronic
musculoskeletal pain.Methods: Fingerlength pattern was determined in a total of 4784
participants of the prospective cohort Rotterdam Study II and III. Hand
X-rays were visually classiﬁed in three different ﬁngerlength pattern
types. Logistic regression was used to analyze the association of type 3
ﬁngerlength pattern with radiological OA of the hip, knee and hand. A
meta-analysis of previous published studies and our results was per-
formed to evaluate the association with kneeOA. Subsequently, we
studied the association of type 3 ﬁngerlength pattern with chronic
musculoskeletal pain.
Results: Participants with type 3 ﬁngerlength pattern had a 64%
increased risk for having handOA (OR 1.64; P-value 1.06*10-7). This
ﬁnding was independent of the severity of the disease. No associations
with knee- or hipOAwere found. The meta-analysis of kneeOA and type
3 ﬁngerlength pattern showed no evidence for association, however
large heterogeneity was observed, which was probably driven by
differences in the OA phenotype deﬁnition. Only studies that had
a clinical deﬁnition, deﬁned by both structural damage to the knee and
pain, showed an association between knee OA and ﬁngerlength
patterns. We therefore examined whether type 3 ﬁngerlength pattern
was associated with chronic joint pain and, we indeed observed that
individuals with a lower 2D:4D ratio had 41% more risk for having joint
pain (OR 1.41; P-value 1.4*10-3).
Conclusions: Type 3 ﬁngerlength pattern is associated with handOA,
indicating prenatal androgens to contribute to the development of this
disease. We additionally observed an association between low 2D:24
ratio and the risk for joint pain. Since prenatal androgens inﬂuences
both the development of ﬁngerlength pattern and the brain, a devel-
opmental cerebral susceptibility for chronic musculoskeletal pain may
underlie the association found with type 3 ﬁngerlength pattern.
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IN VIVO IMAGING OF NF-lB ACTIVITY AND CORRELATION TO PAIN IN
A MODEL OF INFLAMMATORY ARTHRITIS
R.D. Bowles y, B.A. Mata z, T.K. Mwangi y, G.M. Palmer x,
L.A. Setton y,z. yDept. of BioMed. Engineering, Duke Univ., Durham, NC,
USA; zDept. of Orthopaedic Surgery, Duke Univ., Durham, NC, USA;
xDept. of Radiation Oncology, Duke Univ., Durham, NC, USA
Purpose: A number of pro-inﬂammatory and catabolic changes are
observed during the progression of osteoarthritis. However, the rela-
tionship between these changes, the molecular events that regulate
these changes, and the development of painful symptoms is incom-
pletely understood. Many of the pro-inﬂammatory and catabolic
pathways rely on the downstream effects of NF-lB activity, a key
transcription factor involved in regulating inﬂammation. This study
utilized non-invasive in vivo luminescence imaging of NF-lB activity
and simultaneous measures of pain sensitivities in a mouse model of
inﬂammatory arthritis to test for relationships between NF-lB activity
and pain.
Methods: Transgenic mice engineered to carry cDNA for luciferase
downstream of NF-kB response elements were acquired for this study
(n¼24, BALB/C-Tg(NF kB-RE-luc), age 7-8 weeks, Taconic). Mice
received a 5 uL intra-articular injection of normal saline (n¼12) or 10
mg/ml monoiodoacetate (MIA, n¼12). A subset of mice (n¼6/group;
MIA, Saline) were sacriﬁced on day 3 post injection with the remaining
mice being sacriﬁced on day 28 post injection. Mice underwent in vivo
imaging of luminescence to measure NF-lB activity (IVIS100, Caliper)
preoperatively and at intervals from day 1 to 28; mice also underwent
tactile allodynia and incapacitance meter testing at these same time-
points to measure a threshold for paw withdrawal from mechanical
stimuli and weight bearing, respectively. The knees were saved for
histology at time of sacriﬁce.
Results: MIA injection induced arthritic changes in the NF-lB reporter
transgenic mouse model including NF-lB activity, joint degradation,
and the development of pain sensitivities. NF-lB activity was signiﬁ-
cantly increased in the knee ROI after injection on days 1 and 3
compared to preoperative values, and on day 3 when compared to
saline injection (p<0.05, 2-way ANOVA, Tukey Post Hoc) (Fig. 1a,b). The
50% withdrawal threshold was signiﬁcantly decreased for MIA injection
on days 3 and 7 compared to preoperative values, and signiﬁcantly
decreased on days 3, 7, 21, and 28 when compared to saline injection
(p<0.05, 2-way ANOVA, Tukey Post Hoc) (Fig. 1c). Weight distribution
signiﬁcantly shifted to the contralateral limb for MIA injection animals
on days 3 and 7 when compared to pre-operative values (p<0.05) and
on day 3 when compared to Saline injection (p<0.05) (Fig. 1d). A
